Europe Short-read Sequencing Market Size & Outlook
Europe short-read sequencing market, 2018-2030 (US$M)
Related Markets
Europe short-read sequencing market highlights
- The Europe short-read sequencing market generated a revenue of USD 1,364.4 million in 2023.
- The market is expected to grow at a CAGR of 17.5% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 1,364.4 million |
| Market revenue in 2030 | USD 4,217.0 million |
| Growth rate | 17.5% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Birks Group Inc Class A, Qiagen NV, Agilent Technologies Inc, Macrogenics Inc, Azenta Inc, PerkinElmer, ProPhase Labs Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 23.9% of the global short-read sequencing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,797.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Short-read Sequencing Market Scope
Short-read Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe short-read sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to short-read sequencing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 62.57% in 2023. Horizon Databook has segmented the Europe short-read sequencing market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
The European short read sequencing market is expected to grow with a steady pace during the forecast period at a CAGR of XX% from 2017-2025. This is majorly due to support from government and non-government organizations towards R&D for genomic medicine.
Furthermore, presence of national and international organizations, such as the European Union (EU) and European Bioinformatics Institute (EBI) further accelerates the region's progress. It provides monetary as well as knowledge support to numerous genomic projects conducted by researchers across European countries.
In addition, international collaborations between European genomic institutes such as EMBL with companies such as Illumina and BGI for the growth of genomic research is expected to propel the market growth.
Reasons to subscribe to Europe short-read sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe short-read sequencing market databook
-
Our clientele includes a mix of short-read sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe short-read sequencing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe short-read sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe short-read sequencing market size, by country, 2018-2030 (US$M)
Europe Short-read Sequencing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
